Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA

Cited by (472)

Items 201–300 of 472

1. The development and improvement of ribonucleic acid therapy strategies
   Yuxi Zhao, Rui Shu, Jiang Liu · 2021 · Molecular Therapy — Nucleic Acids
2. Current state of, prospects for, and obstacles to mRNA vaccine development
   Alaa A. A. Aljabali, Rasha M. Bashatwah, Mohammad A. Obeid, Vijay Mishra, Yachana Mishra, Ángel Serrano‐Aroca, Kenneth H. Lundstrom, Murtaza M. Tambuwala · 2022 · Drug Discovery Today
3. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines
   Christopher Manners, Erick Larios Bautista, Hannah Sidoti, Osvaldo J. López · 2020 · Cureus
4. The Next Generation of Influenza Vaccines: Towards a Universal Solution
   Christopher L. D. McMillan, Paul R. Young, Daniel Watterson, Keith J. Chappell · 2021 · Vaccines
5. Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics
   Li Zeng, Dongying Li, Weida Tong, Tieliu Shi, Baitang Ning · 2021 · Biochemical Pharmacology
6. Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines
   Azam Bolhassani · 2022 · Molecular Biotechnology
7. mRNA COVID-19 Vaccines—Facts and Hypotheses on Fragmentation and Encapsulation
   Jacques Demongeot A, Cécile Fougère · 2022 · Vaccines
8. Novel Vectors and Administrations for mRNA Delivery
   Chenghai Bai, Chen Wang, Yuan Lu · 2023 · Small
9. mRNA-Based Vaccines and Mode of Action
   Janina Gergen, Benjamin Petsch · 2020 · Current topics in microbiology and immunology
10. An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
    M. M. Rahman, Nan Zhou, Jian‐Dong Huang · 2021 · Vaccines
11. Advances in nanomedicine for the treatment of infectious diseases caused by viruses
    Somya Ranjan Dash, Chanakya Nath Kundu · 2023 · Biomaterials Science
12. Nanoemulsion nasal adjuvant W805EC induces dendritic cell engulfment of antigen-primed epithelial cells
    Andrzej Myc, Jolanta F. Kukowska‐Latallo, Douglas M. Smith, Crystal Passmore, Tiffany Pham, Pamela T. Wong, Anna U. Bielinska, James R. Baker · 2012 · Vaccine
13. Resistance of Pancreatic Carcinoma Cells Is Reversed by Coculturing NK-like T Cells with Dendritic Cells Pulsed with Tumor-Derived RNA and CA 19-9
    Carsten G. Ziske, Angela Märten, Björn Schöttker, Peter Buttgereit, Frank Schakowski, Marcus Gorschlüter, Alexander von Rücker, Christian Scheffold, Nelson Jen An Chao, Tilman Sauerbruch et al. · 2001 · Molecular Therapy
14. Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders
    Porkizhi Arjunan, Durga Kathirvelu, Gokulnath Mahalingam, Ashish Goel, Uday George Zacharaiah, Alok Srivastava, Srujan Kumar Marepally · 2024 · Acta Pharmaceutica Sinica B
15. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
    Nina Marí Gual Pimenta de Queiroz, Fabio Vitarelli Marinho, Marcelo Chagas, Luciana C. C. Leite, E. Jane Homan, Mariana T. Q. de Magalhães, Sergio Costa Oliveira · 2020 · Microbes and Infection
16. Nucleic acid delivery and nanoparticle design for COVID vaccines
    Jason L. Andresen, Owen S. Fenton · 2021 · MRS Bulletin
17. Have mRNA vaccines sentenced DNA vaccines to death?
    Alberto Cagigi, Bruno G. Douradinha · 2023 · Expert Review of Vaccines
18. The European Regulatory Environment of RNA-Based Vaccines
    Thomas Hinz, Kajo Kallen, Cedrik Michael Britten, Bruno Flamion, Ulrich Granzer, Axel Hoos, Christoph Huber, Samir N. Khleif, Sebastian Kreiter, Hans‐Georg Rammensee et al. · 2016 · Methods in molecular biology
19. mRNA-based HIV-1 vaccines
    Shamim Ahmed, Alon Herschhorn · 2024 · Clinical Microbiology Reviews
20. Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa
    Jozefien Declercq, Sarah Gerlo, Sharon Van Nevel, Natalie De Ruyck, Gabriële Holtappels, Liesbeth M. Delesie, Els Tobback, Inés Lammens, Nikita Gerebtsov, Koen Sedeyn et al. · 2024 · Science Translational Medicine
21. In-vitro Transcribed mRNA Delivery Using PLGA/PEI Nanoparticles into Human Monocyte-derived Dendritic Cells.
    Zarin Sharifnia, Mojgan Bandehpour, Hamed Hamishehkar, Nariman Mosaffa, Bahram Kazemi, Nosratollah Zarghami · 2019 · PubMed Central
22. Clinical advancements in mRNA vaccines against viral infections
    Munazza Tamkeen Fatima, Pil‐Gu Park, Kee‐Jong Hong · 2024 · Clinical Immunology
23. Anti-Influenza Strategies Based on Nanoparticle Applications
    Klaudia Wieczorek, Barbara Szutkowska, Elżbieta Kierzek · 2020 · Pathogens
24. In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
    Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, Montserrat Plana, Felipe García, Lorna Leal · 2021 · Viruses
25. The Coming of Age of Nucleic Acid Vaccines during COVID-19
    Halie M. Rando, Ronan Lordan, Likhitha Kolla, Elizabeth Sell, Alexandra J. Lee, Nils Wellhausen, Amruta S. Naik, Jeremy P. Kamil, Anthony Gitter, Casey S. Greene et al. · 2023 · mSystems
26. Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus
    Hai Xu, Shanyuan Zhu, Roshini Govinden, Hafizah Yousuf Chenia · 2023 · Viruses
27. Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
    Alberto Rubio‐Casillas, David Cowley, Mikolaj Raszek, Vladimir Nikolaevich Uversky, Elrashdy M Moustafa Mohamed Redwan · 2024 · International Journal of Biological Macromolecules
28. In vivo protein expression from mRNA delivered into adult rat brain
    Karikó, Katalin, Keller, Jason M., Harris, Valerie A., Langer, David J., Welsh, Frank A. · 2001 · Journal of Neuroscience Methods
29. RNA as a tumor vaccine: a review of the literature
    Judit Saenz-Badillos, Sabina Amin, Richard D. Granstein · 2001 · Experimental Dermatology
30. Vaccines against COVID-19: Priority to mRNA-Based Formulations
    Steve Pascolo · 2021 · Cells
31. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA
    I. Dimier‐Poisson, Fleur Aline, Daniel T. Bout, Marie-Noëlle Mévélec · 2005 · Vaccine
32. Advancements in RNA-based therapies from bench to bedside
    Amrita Singh, Muktika Tekade, Sreeharsha Nagaraja, Azad Bharti, Rakesh Kumar Tekade · 2026 · npj Drug Discovery.
33. HIV and Messenger RNA Vaccine
    Khizer Khalid, Jaskamal Padda, Anwar Khedr, Dina Ismail, Ujala Zubair, Ola A Al-Ewaidat, Sandeep Padda, Ayden Charlene Cooper, Gutteridge Jean-Charles · 2021 · Cureus
34. Intranasal delivery of vaccines against HIV
    Michael Vajdy, Manmohan Singh · 2006 · Expert Opinion on Drug Delivery
35. Immunization against Viral Proteins with Naked DNA
    Jeffrey B. Ulmer, John Donnelly, R. Randall Deck, Corrille M. DeWitt, Margaret A. Liu · 1995 · Annals of the New York Academy of Sciences
36. Tumor Vaccines
    Freda K. Stevenson, Jason Rice, Delin Zhu · 2004 · Advances in immunology
37. mRNA vaccines engage unconventional pathways in CD8+ T cell priming
    Suin Jo, Lijin Li, Chandrani Thakur, Kevin A. Telfer, Hussein Sultan, Ray A. Ohara, Michelle He, Giri Nam, Jing Chen, Feiya Ou et al. · 2026 · Nature
38. Material Design for Next-Generation mRNA Vaccines Using Lipid Nanoparticles
    Akon Higuchi, Tzu‐Cheng Sung, Ting Wang, Qing‐Dong Ling, Suresh S. Kumar, Shih-Tien Hsu, Akihiro Umezawa · 2022 · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics
39. mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
    Ziyang Xu, David E. Fisher · 2023 · Frontiers in Immunology
40. Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
    Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, Bo Sun · 2024 · Biomolecules
41. Approaches to Enhance the Potency of Vaccines in Chickens
    Oenone Bodman-Harris, Christine S. Rollier, Munir Iqbal · 2024 · Vaccines
42. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA
    Laura Taina-González, María de la Fuente · 2022 · Pharmaceutics
43. mRNA-based therapies: Preclinical and clinical applications
    Musga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, Sarah E. Knudsen, Farrukh Vohidov, Andoni Garitano-Trojaola · 2022 · International review of cytology
44. Emerging features of MAIT cells and other unconventional T cell populations in human viral disease and vaccination.
    Carl-Philipp Hackstein, Paul Klenerman · 2022 · Seminars in Immunology
45. Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression
    Matthias Zadory, Elliot Lopez, Samuel Babity, Simon‐Pierre Gravel, Davide Brambilla · 2022 · Biomaterials Science
46. Lipid Nanocarrier‐Based mRNA Therapy: Challenges and Promise for Clinical Transformation
    Wenchao Li, Chen Wang, Yifei Zhang, Yuan Lu · 2024 · Small
47. Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?
    Timothy John Mahony, Tatiana E. Briody, Sheila Cecily Ommeh · 2024 · Vaccines
48. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
    Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick B. Arbuthnot · 2020 · Advanced Drug Delivery Reviews
49. Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines
    Petra Riedl, J�rg Reimann, Reinhold Schirmbeck · 2004 · Journal of Molecular Medicine
50. RNA Based Vaccines
    Georgetta Cannon, Drew Weissman · 2002 · DNA and Cell Biology
51. Benzoyl and Pivaloyl as Efficient Protecting Groups for Controlled Enzymatic Synthesis of DNA and XNA Oligonucleotides
    Marie Flamme, Dace Katkevica, Kārlis Pajuste, Mārtiņš Katkevičs, Nazarii Sabat, Steven Paul Hanlon, Irene Marzuoli, Kurt Püntener, Filippo Sladojevich, Marcel Hollenstein · 2022 · Asian Journal of Organic Chemistry
52. Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA Vaccines
    Jiayu Gu, Zhourui Xu, Qiqi Liu, Shiqi Tang, Wenguang Zhang, Shouxia Xie, Xiaoyan Chen, Jiajie Chen, Ken‐Tye Yong, Chengbin Yang et al. · 2023 · Advanced Healthcare Materials
53. RNA nanotechnology: A new chapter in targeted therapy
    Tongtong Lv, Yingying Meng, Yifan Liu, Yukun Han, Hongwu Xin, Xiaochun Peng, Jinbai Huang · 2023 · Colloids and Surfaces B Biointerfaces
54. Cancer Vaccines. Any Future?
    Lukasz A. Myc, Andrzej Gamian, Andrzej Myc · 2011 · Archivum Immunologiae et Therapiae Experimentalis
55. Lipoplexes Carrying mRNA Encoding Gag Protein Modulate Dendritic Cells to Stimulate HIV-Specific Immune Responses
    Winni De Haes, Joanna Rejman, Charlotte Pollard, Céline Merlin, Marc Vekemans, Éric Florence, Stefaan C. De Smedt, Johan Grooten, Guido L. Vanham, Stefaan De Koker et al. · 2012 · Nanomedicine
56. mRNA vaccine development and applications: A special focus on tumors (Review)
    Bangjie Chen, Yipin Yang, Xinyi Wang, Wenzhi Yang, You Lu, Daoyue Wang, Enba Zhuo, Yanchao Tang, Junhong Su, Guozheng Tang et al. · 2024 · International Journal of Oncology
57. N1-methylpseudouridine-incorporated mRNA enhances exogenous protein expression and suppresses immunogenicity in primary human fibroblast-like synoviocytes
    Sho Mokuda, Hirofumi Watanabe, Hiroki Kohno, Michinori Ishitoku, Kei Araki, Shintaro Hirata, Eiji Sugiyama · 2022 · Cytotechnology
58. Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies
    Munazza Fatima, Timothy An, Kee‐Jong Hong · 2025 · Biomolecules
59. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans
    Keshav Goyal, Harsh Goel, Pritika Baranwal, Anisha Tewary, Aman Dixit, Avanish Kumar Pandey, Mercilena Benjamin, Pranay Tanwar, Abhijit Dey, Fahad Khan et al. · 2021 · Immuno
60. DNA vaccines expressing antigens with a stress protein‐capturing domain display enhanced immunogenicity
    Jörg Reimann, Reinhold Schirmbeck · 2004 · Immunological Reviews
61. Zika virus—an update on the current efforts for vaccine development
    Victória Alves Santos Lunardelli, Juliana de Souza Apostólico, Edgar Ruz Fernandes, Daniela Santoro Rosa · 2020 · Human Vaccines & Immunotherapeutics
62. COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective
    Cavaillon, Jean-Marc, Osuchowski, Marcin F. · 2021 · Journal of Intensive Medicine
63. The mRNA vaccine platform for veterinary species
    Fatemeh Fazel, Janan Shoja Doost, Sugandha Raj, Nitish Boodhoo, Khalil Karimi, Shayan Sharif · 2024 · Veterinary Immunology and Immunopathology
64. COVID-19 vaccines: Frequently asked questions and updated answers
    Maeva Lefebvre, Nicolas Vignier, Bruno Pitard, Élisabeth Botelho-Nevers, Benjamin Wyplosz, Robert Cohen, Olivier Épaulard · 2021 · Infectious Diseases Now
65. The repeated setbacks of HIV vaccine development laid the groundwork for SARS-CoV-2 vaccines
    Jeffrey E. Harris · 2022 · Health Policy and Technology
66. Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
    Elias Joseph Sayour, Luis A Sanchez-Perez, Catherine Flores, Duane A. Mitchell · 2015 · Journal for ImmunoTherapy of Cancer
67. Recombinant vaccine delivery systems and encoded vaccines
    Charles Kendall Stover · 1994 · Current Opinion in Immunology
68. mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes
    Arina A. Ibragimova, A. A. Fedorov, Kirill M. Kirilenko, Е. Л. Чойнзонов, Evgeny V. Denisov, Marina R. Patysheva · 2025 · Acta Naturae
69. Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
    Wubetu Yihunie Belay, Getinet Nibret, Yibeltal Aschale · 2023 · Clinical Pharmacology Advances and Applications
70. mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
    Sarfaraz K. Niazi, Matthias Magoola · 2023 · Biologics
71. Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions
    H. S. Jeffrey Man, Vaneeza A. Moosa, Anand Narayan Singh, Licun Wu, John Thomas Granton, S. Juvet, Chuong D. Hoang, Marc E. de Perrot · 2023 · Frontiers in Genetics
72. mRNA Vaccine for Alzheimer’s Disease: Pilot Study
    Armine Hovakimyan, Garri Chilingaryan, Olga King, Joia Kai Capocchi, Jean Paul Chadarevian, Hayk Davtyan, R. Kniazev, Michael G. Agadjanyan, Anahit Ghochikyan · 2024 · Vaccines
73. Current Efforts on Generation of Optimal Immune Responses against HIV through Mucosal Immunisations
    Michael Vajdy · 2006 · Drugs in R&D
74. Efficacy and limitations of repurposed drugs and vaccines for COVID-19
    Nensina Murmu, Mrinmoy Sarkar, Sananda Dey, Rahul Manna, Shreya Roy, Tanushree Mondal, Soma Halder, Nandini Bhattacharjee, Sandeep Kumar Dash, Biplab Giri · 2023 · Journal of Medicine Surgery and Public Health
75. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches
    Piotr Rzymski, Aliyu Tijani Jibril, Laila Rahmah, Sunny Okechukwu Abarikwu, Fareeda Hashem, Abdullah Al Lawati, Fiona McGowan Martha Morrison, Leander Penaso Marquez, Kawthar Mohamed, Amjad Khan et al. · 2024 · Journal of Medical Virology
76. Strategies for Organ‐Targeted mRNA Delivery by Lipid Nanoparticles
    Hangping Liao, Jing Ping Liao, Ling Zeng, Xinxiu Cao, Hui Fan, Jinjin Chen · 2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
77. Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs
    Malcolm S. Duthie, Bruna Aparecida Souza Machado, Roberto José da Silva Badaró, Paul Martin Kaye, Steven G. Reed · 2022 · Pathogens
78. Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer
    Hans‐Georg Rammensee · 2006 · Immunology and Cell Biology
79. DNA Vaccines for the Induction of Immune Responses in Mucosal Tissues
    Milan Raška, Jaroslav Tuřánek · 2015 · Elsevier eBooks
80. Antibody production by in vivo RNA transfection
    Bizhan Romani, Amirarsalan Kavyanifard, Elham Allahbakhshi · 2017 · Scientific Reports
81. The Immunology of DNA Vaccines
    Thomas Tüting, Jonathan M. Austyn, Walter J. Storkus, Louis D. Falo · 2003 · Humana Press eBooks
82. Priming Biologically Active Antibody Responses Against an Isolated, Conformational Viral Epitope by DNA Vaccination
    Petra Riedl, Shereen El Kholy, Jörg Reimann, Reinhold Schirmbeck · 2002 · The Journal of Immunology
83. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
    Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, Rino Rappuoli · 2022 · Pharmacological Reviews
84. mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
    Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, Paolo Giuliani, Florigio Romano Lista, Simonetta Salemi, Roberto Paganelli · 2024 · Vaccines
85. Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences
    Robert E. Rhoads · 2016 · Methods in molecular biology
86. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA
    Yasser Osman, Miwako Narita, Flávio Monteiro Ayres, Masayuki Takahashi, Louie Alldawi, F. Tatsuo, K. Toba, T. Hirohashi, Yoshiyasu Aizawa · 2003 · Cytotherapy
87. A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge
    Yuying Tian, Zhuoya Deng, Zhengran Chuai, Cong Li, Liangzheng Chang, Fang Sun, Rui Cao, Hongyu Yu, Ruixue Xiao, Shuai Lü et al. · 2024 · Virology
88. Pharmaceutical strategies for optimized mRNA expression
    Yingying Shi, Jiapeng Mao, Sijie Wang, Siyao Ma, Lihua Luo, Jian You · 2024 · Biomaterials
89. Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
    Zhimeng Wei, Shuai Zhang, Xingya Wang, Ying Xue, Sheng Dang, Jingbo Zhai · 2025 · Frontiers in Immunology
90. Therapeutic mRNA vaccine applications in oncology
    Leighton Andrew Elliott, Timothy P. Foster, Paul Castillo, Héctor Méndez-Gómez, Elias Joseph Sayour · 2025 · Molecular Therapy
91. Technologies for making new vaccines
    Ronald W. Ellis, Rino Rappuoli, Sohail Ahmed · 2013 · Elsevier eBooks
92. RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement
    Hana M. Abdelzaher, Asmaa S. Gabr, Basma M. Saleh, Rana M. Abdel Gawad, Ahmed A. Nour, Anwar Abdelnaser · 2021 · Vaccines
93. Vaccines on demand, part II: future reality
    Geall, Andrew J., Kis, Zoltan, Ulmer, Jeffrey B. · 2023 · Expert Opinion on Drug Discovery
94. The mRNA-Based Innovative Strategy: Progress and Challenges
    Huayuan Zhou, Dali Wei, Zhejie Chen, Hao Chen, Chuhuang Dong, Weiyao Cai, Jiawen Wang, Xueliang Liu, Yuqing Li, Yu Yang et al. · 2026 · Nano-Micro Letters
95. The Bright Future of mRNA as a Therapeutic Molecule
    Dora Emma Vélez, Blanca Licia Torres, Greco Hernández · 2025 · Genes
96. mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives
    Silpa Suman Pati, Shrestha Dhal, Ritesh Pattnaik, Sugato Tripathy, Subrat Kumar · 2025 · Current Medical Science
97. Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo
    Yitian Xu, Lu Huang, Jonathan L. Kirschman, Daryll A. Vanover, Pooja Munnilal Tiwari, Philip J. Santangelo, Xiling Shen, David G. Russell · 2018 · The Journal of Immunology
98. Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec
    Damon R. Asher, Daisy Dai, Alexa C. Klimchak, Lauren E. Sedita, Katherine L. Gooch, Louise R. Rodino‐Klapac · 2023 · Molecular Therapy — Methods & Clinical Development
99. Technologies for Making New Vaccines
    Syed Sohail Ahmed, Ronald W. Ellis, Rino Rappuoli · 2017 · Elsevier eBooks
100. Nucleic acid vaccines
     Raymond E. Spier · 1995 · Vaccine